Elisabeth Casañas-Gil

Suggest Changes
Learn More
BACKGROUND Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly(More)
  • 1